External funding opportunities – open calls

As one of the largest healthcare initiatives worldwide, each year EIT Health awards funding to healthcare projects that are proactively addressing a diverse range of health challenges. EIT Health is only one funding mechanism in the European healthcare ecosystem and below you can find a selection of currently open funding programmes offered by external parties. 

1. Horizon 2020 postponed calls  

Deadline 12 May 2020

Deadline 04 June 2020

Deadline 17 June 2020

Deadline 18 June 2020

2. EIC: European Innovation Council

The EIC aims to support top-class innovators, entrepreneurs, small companies and researchers with bright ideas and the ambition to scale-up internationally. A total amount of around €3 billion will be provided throughout the period 2018-2020 to innovators from all EU Member States, countries associated to the EU Horizon 2020 program, and innovators from all parts of the world who have established their activities in Europe.

No specific submission deadline. 

3. Fast Track to Innovation (FTI)

The Fast Track to Innovation (FTI) is a fully-bottom-up innovation support programme promoting close-to-the-market innovation activities open to industry-driven consortia that can be composed of all types of participants. It can help partners to co-create and test breakthrough products, services or business processes that have the potential to revolutionise existing or create entirely new markets. Proposals must come from consortia of 3 to 5 legal entities who want to see quick market uptake of new technologies. Grants of up to €3 million may be awarded.

The call has opened on 7 November 2017 and will be continuously open until 27 October 2020. Proposals are evaluated and ranked and funding decisions taken after three cut-off dates each year.

4. IMI – Innovative Medicines Initiative 2

The primary goal of IMI2 is the faster development of safe and effective medicines, but also addressing societal challenges in the European healthcare system, such as the ageing population or the increasing risk of antimicrobial resistance.

IMI2 – Calls 22 and 23, scheduled for launch on 23 June 2020.

5. Eurostars

Eurostars is a joint funding program of the EUREKA association and the European Commission. The aim of Eurostars is to motivate small and medium-sized enterprises (SMEs) to cooperate in European research and development projects. The projects submitted should  aim to develop an innovative product, process or service.

Dates: Applications can be submitted at any time, with review rounds usually taking place twice a year.

6. SME Innovative (BMBF)

KMU-Innovative is a program within the framework of the High Tech Strategy 2025 to promote cutting-edge research in SMEs. The aim is to minimise risks for innovative R&D projects, to improve cooperation between SMEs and large companies, as well as with research institutions, and to accelerate technology transfer.

Dates: Project outlines can be submitted at any time. Assessment deadlines are generally April 15 and October 15 of each year.

7. BMBF: “Translation Projects Personalised Medicine”

Module 1: Development of new diagnostics and therapies for personalized medicine

Module 2: Integrated research platforms for implementing personalized treatment approaches in clinical practice

Deadline: projects must first be submitted in writing and / or electronically by June 30, 2020. 

8. Call for funding to research COVID-19 following the outbreak of Sars-CoV-2

Individual projects and, in justified exceptions, small research associations (with up to three partners at different institutions) are supported, which are based on WHO’s priority settings and address the following points:

– the biology of the virus and its transmission;

– Animal and environmental research on the origin of the virus, including control measures at the human-animal interface;

– epidemiological studies;

– clinical characterization and clinical management of the diseases caused by the virus;

– infection prevention and control, including the best ways to protect healthcare workers;

– Research and development of medicines and other therapeutic methods as well as the development of new diagnostic approaches (research on vaccine development and market-oriented diagnostics development are not the subject of the funding);

– Accompanying research and ELSA research in connection with the outbreak.

Deadline: 11 May 2020

9. Seed-Financing (Austria) 

This funding and advisory program supports the (pre) foundation and development of young, innovative and technology-oriented companies in all technology sectors from concept to company foundation and in the first years of entrepreneurial activity with a conditionally repayable grant of up to 800,000.00 Euro.

10. Minister Schramböck und and Minister Gewessler: About 16 millions of funding for 24 projects in Corona Research (Austria)

11. Call for Austria’s Founder Award PHÖNIX (Austria)

12. LISA: Impulse für Österreichs Biotech-Landschaft – Life Sciences Austria

13. Innosuisse – Swiss Agency for Innovation Promotion